Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Frey

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
JAMA|June 26, 2003
Response to smallpox vaccine in persons immunized in the distant pastSharon E Frey, Frances K Newman, Lihan Yan, et al.
The Journal of Infectious Diseases|April 16, 2003
Stability of undiluted and diluted vaccinia-virus vaccine, DryvaxFrances K Newman, Sharon E Frey, Tamara P Blevins, et al.
Clinical and Vaccine Immunology : CVI|July 26, 2013
Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar Typhi vaccine strains from human bloodKathleen R Lottenbach, Sandra M Kelly-Aehle, Karen E Brenneman, et al.
JAMA|February 11, 2005
Immune status in a primary smallpox vaccinee who failed to develop an immunization site reactionJohn M Kelso, Kevin M Kuhn, Frances K Newman, et al.
Vaccine|March 11, 2014
Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individualsSharon E Frey, Patricia L Winokur, Heather Hill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adultsPatricia L Winokur, Theresa E Hegmann, Wendy A Keitel, et al.
Vaccine|August 19, 2007
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adultsRobert B Belshe, Frances K Newman, Ken Wilkins, et al.
Vaccines|May 28, 2025
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based VaccinesGetahun Abate, Krystal Meza, Yinyi Yu, et al.
Journal of Clinical Microbiology|July 5, 2003
Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccineFrances K Newman, Sharon E Frey, Tamara P Blevins, et al.
Vaccines|January 24, 2025
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox ImmunityYinyi Yu, Krystal Meza, Chase Colbert, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
JAMA|June 26, 2003
Response to smallpox vaccine in persons immunized in the distant pastSharon E Frey, Frances K Newman, Lihan Yan, et al.
The Journal of Infectious Diseases|April 16, 2003
Stability of undiluted and diluted vaccinia-virus vaccine, DryvaxFrances K Newman, Sharon E Frey, Tamara P Blevins, et al.
Clinical and Vaccine Immunology : CVI|July 26, 2013
Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar Typhi vaccine strains from human bloodKathleen R Lottenbach, Sandra M Kelly-Aehle, Karen E Brenneman, et al.
JAMA|February 11, 2005
Immune status in a primary smallpox vaccinee who failed to develop an immunization site reactionJohn M Kelso, Kevin M Kuhn, Frances K Newman, et al.
Vaccine|March 11, 2014
Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individualsSharon E Frey, Patricia L Winokur, Heather Hill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adultsPatricia L Winokur, Theresa E Hegmann, Wendy A Keitel, et al.
Vaccine|August 19, 2007
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adultsRobert B Belshe, Frances K Newman, Ken Wilkins, et al.
Vaccines|May 28, 2025
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based VaccinesGetahun Abate, Krystal Meza, Yinyi Yu, et al.
Journal of Clinical Microbiology|July 5, 2003
Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccineFrances K Newman, Sharon E Frey, Tamara P Blevins, et al.
Vaccines|January 24, 2025
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox ImmunityYinyi Yu, Krystal Meza, Chase Colbert, et al.
Pageof 12